Literature DB >> 12142292

The world's most neglected diseases.

Gavin Yamey, Els Torreele.   

Abstract

Keywords:  Health Care and Public Health

Mesh：

Substances：

Year:  2002        PMID： 12142292      PMCID： PMC1123710          DOI： 10.1136/bmj.325.7357.176

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Public sector must develop drugs for neglected diseases.

Authors:  Gavin Yamey
Journal:  BMJ       Date:  2002-03-23

2.  The cost to global health of drug company profits.

Authors:  R MacDonald; G Yamey
Journal:  West J Med       Date:  2001-05

Review 3.  Drug development for neglected diseases: a deficient market and a public-health policy failure.

Authors:  Patrice Trouiller; Piero Olliaro; Els Torreele; James Orbinski; Richard Laing; Nathan Ford
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

Review 4.  Treatment of human African trypanosomiasis--present situation and needs for research and development.

Authors:  Dominique Legros; Gaëlle Ollivier; Marc Gastellu-Etchegorry; Christophe Paquet; Christian Burri; Jean Jannin; Philippe Büscher
Journal:  Lancet Infect Dis       Date:  2002-07       Impact factor: 25.071
  4 in total
  40 in total

1.  Neglected diseases: under-funded research and inadequate health interventions. Can we change this reality?

Authors:  Carlos M Morel
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

2.  Neglected tropical diseases.

Authors:  Gavin Yamey; Peter Hotez
Journal:  BMJ       Date:  2007-08-11

3.  Quantifying the lack of scientific interest in neglected tropical diseases.

Authors:  Dieter Vanderelst; Niko Speybroeck
Journal:  PLoS Negl Trop Dis       Date:  2010-01-26

Review 4.  Social and Economic Burden of Human Leishmaniasis.

Authors:  Ifeoma Okwor; Jude Uzonna
Journal:  Am J Trop Med Hyg       Date:  2016-01-19       Impact factor: 2.345

5.  Three new sensitive and specific heat-shock protein 70 PCRs for global Leishmania species identification.

Authors:  A M Montalvo; J Fraga; I Maes; J-C Dujardin; G Van der Auwera
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-15       Impact factor: 3.267

6.  Usefulness of the rK39-immunochromatographic test, direct agglutination test, and leishmanin skin test for detecting asymptomatic Leishmania infection in children in a new visceral leishmaniasis focus in Amhara State, Ethiopia.

Authors:  Endalamaw Gadisa; Estefanía Custodio; Carmen Cañavate; Luis Sordo; Zelalem Abebe; Javier Nieto; Carmen Chicharro; Abraham Aseffa; Lawrence Yamuah; Howard Engers; Javier Moreno; Israel Cruz
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

7.  Optimum land cover products for use in a Glossina-morsitans habitat model of Kenya.

Authors:  Mark H DeVisser; Joseph P Messina
Journal:  Int J Health Geogr       Date:  2009-06-29       Impact factor: 3.918

8.  Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole.

Authors:  José Carlos Sousa-Figueiredo; Joyce Pleasant; Matthew Day; Martha Betson; David Rollinson; Antonio Montresor; Francis Kazibwe; Narcis B Kabatereine; J Russell Stothard
Journal:  Int Health       Date:  2010-06       Impact factor: 2.473

9.  Achieving a dream: meeting policy goals related to improving drug access.

Authors:  David Zakus; Jillian Clare Kohler; Venera Zakriova; Aaron Yarmoshuk
Journal:  Open AIDS J       Date:  2010-01-19

10.  Measuring morbidity associated with urinary schistosomiasis: assessing levels of excreted urine albumin and urinary tract pathologies.

Authors:  José C Sousa-Figueiredo; María-Gloria Basáñez; I Simba Khamis; Amadou Garba; David Rollinson; J Russell Stothard
Journal:  PLoS Negl Trop Dis       Date:  2009-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.